Fast TILs + IL-2 for Malignant Pleural Effusion • Recruiting Participants for Phase 1 Clinical Trial 2026
Memorial Sloan Kettering is often the first to be aware of the latest scientific discoveries and medical advances for mesothelioma.
Because we’re involved in research related to all aspects of care, Memorial Sloan Kettering is often the first to be aware of the latest scientific discoveries and medical advances for mesothelioma. We’re constantly testing new ways to fight mesothelioma. Our patients have access to clinical trials of new treatment options that are not available in most other hospitals.
They can also give your treatment team information about your current plan of care, and here you can find a continually updated listing of MSK’s current clinical trials for mesothelioma.
Evidence level: Korai humán adat. Kis vagy feltáró emberi adat.
Related signals
- Moving Beyond Morphology: Toward a Morpho‑Molecular Classification of Pleural Mesothelioma
- Comparison of Survival by Multimodal Treatment Regimen Among Malignant Pleural Mesothelioma Patients in an Integrated Health System
- Systemic Treatments for Unresectable Pleural Mesothelioma: A Review of the Literature
- Prognostic impact of somatic mutations among patients with pleural and peritoneal mesothelioma
- Tumor Treating Fields (TTFields) for Pleural Mesothelioma